This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
Communities In Schools (Atlanta): Innovating a College Program
Rangan, V. Kasturi; Applegate, Lynda M.; Lefort, AlexisCase HBS-823070-EEntrepreneurshipFrank Brown, CIS of Atlanta's new Black CEO, was keen to extend CIS's well-honed case management in schools program to youth in college. Founded 50 years ago by Bill Milliken, CIS, a network of 110 affiliates, had built a strong program of assisting and supporting youth in poverty schools to complete their high school education. CIS Atlanta's thrust which would be a new stretch for the network had the strong backing of the network's new national ...Starting at €8.20
-
Mobile Banking for the Unbanked
Rangan, V. Kasturi; Lee, KatharineCase HBS-511049-EMarketingThe case describes in detail the workings of two mobile banking operators in Africa-WIZZIT in South Africa and M-PESA in Kenya. It explores the dimensions of strategy that make for success in the market for the unbanked. It raises questions regarding the portability of the model to other countries and settings.Starting at €8.20
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Diana and Jack Civello: Managing Dual Careers (A, B and C) - Teaching Note
Mitchell, Jordan; Miller, PaddyTeaching Note DPOT-10-ELeadership and People ManagementNote prepared as an aid to instructors in the classroom use of cases DPO-45-E, DPO-46-E and DPO-47-E, Diana and Jack Civello: Managing Dual Careers (A), (B) and (C).Starting at €0.00
-
John Roux at Con Roux Construction - Teaching Note
Miller, PaddyTeaching Note FHT-40-ELeadership and People Management(see case FH-697-E)Starting at €0.00
-
SSS software in-basket exercise - Response documents
Miller, PaddyExercise FHE-14-ELeadership and People ManagementThese forms support the SSS Software In-Basket Exercise. They provide students with a blank detailed diary, day planner, e-mail forms and letters.Starting at €8.20
-
Con Roux Limited - Company Culture - Teaching Note
Miller, Paddy; Dovey K.Teaching Note FHT-31-ELeadership and People Management(See case FH-615-E)Starting at €0.00
-
David Dickens. The Last Ditch Decision - Teaching Note
Miller, PaddyTeaching Note DPOT-4-ELeadership and People ManagementNote prepared as an aid to instructors in the classroom use of case DPO-25-E David Dickens - The Last Ditch Decision.Starting at €0.00